Choshi, Japan

Ishige Kazuya

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Yamasa Corporation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ishige Kazuya. Retrieved from https://idiyas.com/inventor/ishige-kazuya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ishige Kazuya: Innovator in Pharmaceutical Raw Materials

Introduction

Ishige Kazuya is a notable inventor based in Choshi, Japan. He has made significant contributions to the field of pharmaceutical raw materials, particularly through his innovative work on hydrate crystals.

Latest Patents

Ishige holds a patent for a hydrate crystal of 3',3'-cGAMP. This invention addresses the limitations of commonly known lyophilized products, which require a lyophilizer for manufacturing. The need for such specialized equipment restricts mass production capabilities. His invention provides a solution by offering a simple method to produce large quantities of crystals without the need for a lyophilizer. The hydrate crystal of 3',3'-cGAMP is less hygroscopic than existing powders, making it easier to handle and useful as a pharmaceutical raw material.

Career Highlights

Ishige Kazuya is currently employed at Yamasa Corporation, where he continues to innovate in the field of pharmaceutical materials. His work has the potential to enhance the efficiency of drug production and improve the shelf life of pharmaceutical products.

Collaborations

Ishige collaborates with talented coworkers, including Takamatsu Misaki and Yoshida Ko. Their combined expertise contributes to the advancement of innovative solutions in their field.

Conclusion

Ishige Kazuya's contributions to the development of hydrate crystals represent a significant advancement in pharmaceutical raw materials. His innovative approach addresses critical challenges in production and handling, paving the way for more efficient drug manufacturing processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…